The United States does worse than about two dozen other industrialized nations in this crucial measure of public health.
NYT > Research
“You can’t cheat death,” wrote a reader who echoed many responses to an article about drug tests on dogs to try to slow aging. But others said the goal seemed worthy.
In an era of rapidly proliferating, precisely targeted treatments, every cancer case has to be played by ear.
In the early 20th century, the German biochemist Otto Warburg believed that tumors could be treated by disrupting their source of energy. His idea was dismissed for decades — until now.
Andrew Levy’s parents knew that the rare and deadly cancer in his blood could not be beaten, so they began to prepare for the worst. Then something mysterious happened.
Most clinical trials for cancer drugs are failures. But for a handful of patients, a drug proves to be nearly a cure. What can science learn from these “exceptional responders”?
Research points to both advantages and disadvantages. In the end, it’s a personal choice.
New research on potential allergens fits with a wider hypothesis that complete avoidance of risky substances doesn’t work well.
Thanks to Ray Fair, a professor in the economics department at Yale, runners have an exact schedule that will predict how their performance will decline as they age.
Old but only recently published research increases a concern that when it comes to nutrition, personal beliefs can trump science.
Mr. Parker’s institute will try to spur collaboration among six academic centers in developing ways to unleash patients’ immune systems to fight cancer.
Firms promise to help consumers spot metabolic red flags. Critics say the services persuade healthy people to seek unneeded treatment.
Everyone can tell when I’m behind. Every visit is pared to essentials. Paperwork is postponed, chatting minimized.
Those who developed breasts younger than their peers had a higher risk of depression, a new study found.
Moral injury resembles post-traumatic stress disorder with an added burden of guilt, and requires different treatment.
Readers solve the case of a previously healthy 67-year-old gardener who is too exhausted and feverish to garden.
A New York City mother embraces her leading role in a campaign to return to the days when children played and navigated through life without constant adult supervision.
A reader asks: Does rebounding, or a mini-trampoline, provide the miracle benefits that its advocates say it does?
A novel method known as whole genome sequencing focuses on genes that drive a cancer, not the tissues or organ where it originates.
Encouraged by Rwanda’s steady gains in curbing measles, donors are paying for a more expensive dual vaccine that will target rubella, too.
The strains have the same ability to invoke an immune reaction as the live viruses now used to make vaccine do, but with no risk to vaccine factory employees.